EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Patterns and Temporal Dynamics of Pediatric Solid Malignant Tumors: Insights from a 27-Year Referral Center Cohort in Iran (1996–2022)

Maryam Kazemi Aghdam, Yalda Nilipour, Seiedehparnian Taghvaei, Bibi Shahin Shamsian, Samin Alavi, Nader Momtazmanesh, Peyman Eshghi, Gholamreza Ebrahimisaraj, Mehdi Sarafi, Leili Mohajerzadeh, Javad Ghoroubi, Mohsen Rouzrokh, Ahmad Khaleghnejad Tabari

Archives of Iranian Medicine · 2026-03-01 · 29 (3) · 133-147

DOI: 10.34172/aim.35172 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Pediatric solid malignant tumors cause a growing concern with regional variations. Long-term data from Iran are limited. This study examined the temporal trends and distribution of these tumors over 27 years in a large referral cohort, focusing on patterns rather than absolute national incidence. Methods: We retrospectively analyzed 2,579 children diagnosed with solid malignant tumors at Mofid Children’s Hospital, Tehran (1996–2022). Demographics, tumor types, and temporal patterns were assessed. Joinpoint regression evaluated temporal trends using population-standardized and crude rates as analytic denominators for trend assessment. Age–Period–Cohort models were fitted for lymphomas, central nervous system (CNS), and sympathetic nervous system (SNS) tumors. Age-standardized incidence rates (ASIRs) and incidence rate ratios (IRRs) were calculated. Results: Children aged 1-4 years predominated (45.1%). CNS and SNS tumors were most common (40.8%), followed by lymphomas (16.7%). Referral-based population-standardized diagnosis rates increased significantly over time (1996–2022; AAPC=4.81%, P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →